What Is Quality by Design and Why It Matters in PharmaUntitledA Skills-First Introduction
Quality by Design Training in Rwanda gives pharmaceutical and biopharma professionals a systematic, science-based way to build quality into a product from the design stage, rather than testing it in at the end. Quality by Design (QbD) is the approach mandated across the ICH Q8, Q9, Q10 and Q11 guidelines and increasingly expected by regulators such as the FDA and EMA. Over one focused day, you learn to apply the core QbD toolkit: the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment with Ishikawa diagrams and FMEA, Design of Experiments (DoE), the design space and the control strategy. Hands-on exercises use realistic development scenarios so you can apply the method to your own products. The programme suits formulation scientists, process and analytical staff, quality assurance teams and regulatory affairs professionals across Rwanda's growing manufacturing base, from the Kigali Special Economic Zone to established local producers. Build the practical capability employers value, and start applying QbD with Invensis Learning.










